Clarmin Explorations Inc. Share Price Toronto S.E.
Equities
CYBN
CA23256X1006
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 376M 275M 23B |
---|---|---|---|---|---|
Net income 2024 * | -74M -54.09M -4.52B | Net income 2025 * | -70M -51.16M -4.28B | EV / Sales 2024 * | - |
Net cash position 2024 * | 170M 125M 10.41B | Net cash position 2025 * | 126M 91.95M 7.69B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-2.09
x | P/E ratio 2025 * |
-3.6
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.34% |
Latest transcript on Clarmin Explorations Inc.
Managers | Title | Age | Since |
---|---|---|---|
Douglas Drysdale
CEO | Chief Executive Officer | 54 | 01/20/01 |
Paul Glavine
FOU | Founder | 35 | 13/16/13 |
Eric So
FOU | Founder | 49 | 13/16/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric So
FOU | Founder | 49 | 13/16/13 |
Mark Lawson
BRD | Director/Board Member | 52 | 05/20/05 |
Grant Froese
BRD | Director/Board Member | 62 | 05/20/05 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |